The global Blood Plasma Derivatives Market is estimated to be valued at US$ 40.80 Bn In 2022 and is expected to exhibit a CAGR of 9.30% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Blood plasma derivatives are products derived from blood plasma, such as albumin, immunoglobulins, and clotting factors. These products are used for various therapeutic indications, including immunodeficiency disorders, hemophilia, and autoimmune diseases. The advantages of blood plasma derivatives include their ability to replace or replenish deficient proteins in the body, provide passive immunity, and control bleeding in patients with clotting disorders. The increasing prevalence of these conditions and the rising demand for plasma-derived medicines are driving the growth of the blood plasma derivatives market.
Market key trends: An important key trend in the blood plasma derivatives market is the increasing demand for plasma-derived medicines. Plasma-derived medicines are essential for the treatment of various medical conditions, including immune deficiencies, autoimmune diseases, and bleeding disorders. The demand for these medicines is growing due to the increasing global prevalence of these conditions and the expanding aging population. In addition, advancements in plasma fractionation techniques and the development of novel plasma-derived therapies are further fueling market growth. Moreover, the growing awareness among healthcare professionals and patients about the benefits of plasma-derived medicines is also contributing to market expansion.
PEST Analysis:
Political: The political factors influencing the blood plasma derivatives market are mainly focused on regulations and government policies. Government regulations play a crucial role in the approval process of plasma derivatives, which can vary from country to country. Additionally, political stability is important to ensure smooth operations and trade of blood plasma derivatives across different regions.
Economic: The economic factors affecting the Blood Plasma Derivatives Market include healthcare expenditure, insurance coverage, and the overall economic stability in different regions. Increasing healthcare expenditure and rising prevalence of chronic diseases are expected to drive market growth. Additionally, advancements in healthcare infrastructure and increased insurance coverage in emerging economies are expected to boost market demand.
Social: The social factors influencing the market include increasing awareness about blood plasma derivatives, changing lifestyles, and a growing aging population. Rising awareness about the benefits of blood plasma derivatives in treating various diseases is driving market growth. Moreover, lifestyle changes, such as unhealthy dietary habits and lack of physical activity, have led to an increased prevalence of diseases that require plasma derivatives for treatment.
Technological: Technological advancements have played a significant role in the blood plasma derivatives market. Improved manufacturing techniques, such as fractionation and viral inactivation, have enhanced the safety and purity of plasma derivatives. Moreover, the development of new recombinant technologies has expanded the range of plasma-derived products available in the market.
Key Takeaways:
The global blood plasma derivatives market is expected to witness high growth, exhibiting a CAGR of 9.30% over the forecast period. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases, advancements in healthcare infrastructure, and rising awareness about the benefits of blood plasma derivatives.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the blood plasma derivatives market. This can be attributed to factors such as the presence of well-established healthcare infrastructure, high healthcare expenditure, and increasing adoption of advanced therapies in the region.
Key players operating in the blood plasma derivatives market include Shire Plc., CSL Limited, Octapharma AG, LFB S.A., Biotest AG, Grifols, S.A., SK Plasma Co., Ltd., Baxter International Inc., Green Cross Corporation, and Fusion Health Care Pvt. Ltd. These companies are actively involved in research and development activities, strategic collaborations, and mergers and acquisitions to strengthen their market position and expand their product offerings.
Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production.Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen are major players in this market.
Relying on blood supply from around the world, Thermo Fisher, GE Healthcare and Merck (Sigma-Aldrich) are the world’s three giants.
In 2017, Merck (Sigma-Aldrich) is the world leader with a market share of 22.62%North America plays an important role in global bovine blood plasma derivatives market, especially United States, which has great influence on the development of bovine blood plasma derivatives.
In Europe market, Germany, UK, France and Italy are playing significant roles, especially Germany, which has absolute predominance in Europe market.
The Asia-Pacific will take an increasing significant part in global bovine blood plasma derivatives market, due to the strong demand from China, India and Southeast Asian countries.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-bovine-blood-plasma-derivatives-2019-2024-713According to this study, over the next five years the Bovine Blood Plasma Derivatives market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 2080 million by 2024, from US$ 1680 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in Bovine Blood Plasma Derivatives business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Blood Plasma Derivatives market by product type, application, key manufacturers and key regions and countries.This study considers the Bovine Blood Plasma Derivatives value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Bovine SerumFBSBovine Serum AlbuminFibrinogenProtein IngredientOtherSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.Scientific ResearchIndustrial ProductionFeedOthersThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeGermanyFranceUKItalyRussiaSpainMiddle East & AfricaEgyptSouth AfricaIsraelTurkeyGCC CountriesThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.Thermo FisherGE HealthcareMerck (Sigma-Aldrich)Moregate BioTechGeminiAtlanta BiologicalsTissue Culture BiologicalsBovogenBiowestInternegociosRMBIOBiological IndustriesVWRCorningSeranaLanzhou MinhaiZhejiang Tianhang BiotechnologyExCell BioJin Yuan KangAmerican Protein CompanySonacIn addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
